Literature DB >> 9783988

Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer.

M J Droller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9783988     DOI： 10.1016/s0022-5347(01)62450-9

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  3 in total

1.  Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer.

Authors:  Michio Kosugi; Akira Miyajima; Eiji Kikuchi; Takeo Kosaka; Yutaka Horiguchi; Masaru Murai
Journal:  Hum Cell       Date:  2007-02       Impact factor: 4.174

2.  Sunitinib malate synergistically potentiates anti-tumor effect of gemcitabine in human bladder cancer cells.

Authors:  Cheol Yong Yoon; Jung Sun Lee; Bo Sun Kim; Seong Jin Jeong; Sung Kyu Hong; Seok Soo Byun; Sang Eun Lee
Journal:  Korean J Urol       Date:  2011-01-24

3.  Human urothelial carcinoma cell response to Sunitinib malate therapy in vitro.

Authors:  Jin Wen; Han-Zhong Li; Zhi-Gang Ji; Jing Jin
Journal:  Cancer Cell Int       Date:  2015-02-28       Impact factor: 5.722
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.